EPCAM and cancer: Subsequent study has shown that CAR T cells targeting EpCAM on human ovarian and colorectal cancer cells are capable of killing the cancer cells in vitro, and the adaptive transfer of these CAR T cells prolonged the animal survival by eliminating the established ovarian xenografts (Ang et al., 2017).